Immunochemotherapy as induction treatment in Stage III (N2, N3) Non-small cell lung cancer
Hongsheng Deng, Hengrui Liang, Wei Wang, Jianfu Li, Shan Xiong, Bo Cheng, Caichen Li, Qing Ai, Zhuxing Chen, Haixuan Wang, Wenhua Liang, Jianxing He
doi: https://doi.org/10.1101/2021.06.03.21257757
Hongsheng Deng
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Hengrui Liang
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Wei Wang
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Jianfu Li
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Shan Xiong
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Bo Cheng
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Caichen Li
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Qing Ai
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Zhuxing Chen
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Haixuan Wang
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Wenhua Liang
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD.Jianxing He
1Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China
MD, PhD, FACSData Availability
All data included in this study are available upon request by contact with the corresponding author.
Posted June 05, 2021.
Immunochemotherapy as induction treatment in Stage III (N2, N3) Non-small cell lung cancer
Hongsheng Deng, Hengrui Liang, Wei Wang, Jianfu Li, Shan Xiong, Bo Cheng, Caichen Li, Qing Ai, Zhuxing Chen, Haixuan Wang, Wenhua Liang, Jianxing He
medRxiv 2021.06.03.21257757; doi: https://doi.org/10.1101/2021.06.03.21257757
Immunochemotherapy as induction treatment in Stage III (N2, N3) Non-small cell lung cancer
Hongsheng Deng, Hengrui Liang, Wei Wang, Jianfu Li, Shan Xiong, Bo Cheng, Caichen Li, Qing Ai, Zhuxing Chen, Haixuan Wang, Wenhua Liang, Jianxing He
medRxiv 2021.06.03.21257757; doi: https://doi.org/10.1101/2021.06.03.21257757
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3625)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2330)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)